1. Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis. (March 2021) Authors: Kuzin, Maxim; Haen, Ekkehard; Hiemke, Christoph; Bochon, Benjamin; Bochon, Karolina; Gründer, Gerhard; Paulzen, Michael; Schoretsanitis, Georgios Journal: Journal of psychopharmacology Issue: Volume 35:Number 3(2021) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Changes in Clozapine Bioavailability in a Percutaneous Endoscopic Gastrostomy-Fed Patient With Treatment-Resistant Schizophrenia. Issue 3 (May 2020) Authors: Kuzin, Maxim; Bochon, Benjamin; Vagiaris, Efstratios; Dammann, Gerhard; Gründer, Gerhard; Paulzen, Michael; Schoretsanitis, Georgios Journal: Journal of clinical psychopharmacology Issue: Volume 40:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetic Interaction Between Valproic Acid, Meropenem, and Risperidone. Issue 1 (February 2016) Authors: Paulzen, Michael; Eap, Chin-Bin; Gründer, Gerhard; Kuzin, Maxim Journal: Journal of clinical psychopharmacology Issue: Volume 36:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetic interactions between clozapine and sertraline in smokers and non‐smokers. Issue 4 (11th May 2020) Authors: Kuzin, Maxim; Schoretsanitis, Georgios; Haen, Ekkehard; Ridders, Florian; Hiemke, Christoph; Gründer, Gerhard; Paulzen, Michael Journal: Basic & clinical pharmacology & toxicology Issue: Volume 127:Issue 4(2020) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Switching From Aripiprazole Tablets to Oral Suspension in a Patient With Roux-en-Y Gastric Bypass: A Case Report. Issue 3 (May 2023) Authors: Kuzin, Maxim; Schoretsanitis, Georgios; Gardin, Fabian; Markus, Götschi; Kawohl, Wolfram; Xepapadakos, Franziskos Journal: Journal of clinical psychopharmacology Issue: Volume 43:Issue 3(2023) Page Start: 300 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The role of cytochrome P450 enzyme genetic variants in cannabis hyperemesis syndrome—A case report. Issue 1 (27th March 2021) Authors: Kuzin, Maxim; Xepapadakos, Franziskos; Scharrer, Isabel; Augsburger, Marc; Eap, Chin‐Bin; Schoretsanitis, Georgios Journal: Basic & clinical pharmacology & toxicology Issue: Volume 129:Issue 1(2021) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine—A case report. Issue 4 (18th May 2020) Authors: Kuzin, Maxim; Scharrer, Isabel; Nolan, Daniele; Baumgartner, Markus; Paulzen, Michael; Schoretsanitis, Georgios; Xepapadakos, Franziskos Journal: Basic & clinical pharmacology & toxicology Issue: Volume 127:Issue 4(2020) Page Start: 354 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗